ArticleJournal of medicinal chemistry2013

Bivalent ligands that target μ opioid (MOP) and cannabinoid1 (CB1) receptors are potent analgesics devoid of tolerance.

Morgan Le Naour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.